Investigation findings
In a short time, more than 100 patients contacted the site and volunteered for the study, even though they know that it is only a short safety study, not a long-term treatment for them. Jesse Cedarbaum, professor, neurologist, and clinical trialist at Yale School of Medicine, told Tides Global that current treatments mostly focus on symptoms
Since its discovery in 1973, in vivo and in vitro studies have shown that GHK-Cu possesses a wealth of health-positive actions including improving wound contraction and epithelization, and increasing the production of growth factors and activity of antioxidant enzymes
Frontiers in Sustainable Food Systems, 5 , 745865
However, it's important to note that there are no microdosing studies involving DSIP, and the topic should be approached with caution
Bacteriostatic Water: A Comprehensive Understanding